新型抗帕金森氏病化合物FLZ与人和大鼠血浆蛋白结合率的测定
Determination of Human and Rat Plasma Protein Binding Rate of the Novel Anti-Parkinson’s Disease Candidate Drug FLZ
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|